Importantly, consistent conclusions on HSPA2 as a marker of poor outcome for pancreatic cancer patients were obtained analyzing HSPA2 expression in primary tumors at mRNA level [13]. The gene discussed is HSPA2; the disease is pancreatic neoplasm.